Drug Shortage Report for TARO-TOFACITINIB
Report ID | 250059 |
Drug Identification Number | 02511304 |
Brand name | TARO-TOFACITINIB |
Common or Proper name | Tofacitinib |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TOFACITINIB |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 180 |
ATC code | L04AF |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2025-01-01 |
Estimated end date | 2025-05-16 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-05-12 |
Company comments | Inventory is available with June 2025 dating |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2025-05-12 | French | Compare |
v7 | 2025-05-12 | English | Compare |
v6 | 2025-04-24 | French | Compare |
v5 | 2025-04-24 | English | Compare |
v4 | 2025-04-04 | French | Compare |
v3 | 2025-04-04 | English | Compare |
v2 | 2025-02-10 | French | Compare |
v1 | 2025-02-10 | English | Compare |
Showing 1 to 8 of 8